Banque Cantonale Vaudoise Vyne Therapeutics Inc. Transaction History

Banque Cantonale Vaudoise

  • $2.43 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 02, 2022
SELL
$0.37 - $0.71 $0 - $0
-1 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$0.91 - $1.5 $72,799 - $119,998
-79,999 Reduced 100.0%
1 $0
Q3 2021

Oct 29, 2021
SELL
$1.39 - $3.47 $166,800 - $416,400
-120,000 Reduced 60.0%
80,000 $111,000
Q2 2021

Aug 11, 2021
BUY
$3.24 - $6.92 $648,000 - $1.38 Million
200,000 New
200,000 $702,000

Others Institutions Holding VYNE

# of Institutions
2
Shares Held
36.5K
Call Options Held
0
Put Options Held
0
View Full List

About VYNE Therapeutics Inc.

VYNE Quotes by TradingView
  • Ticker VYNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,005,600
  • Market Cap $184M
  • Description
  • VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing various therapeutics for the treatment of immuno-inflammatory conditions. The company develops FCD105, a topical combination foam that has completed Phase III clinical trials for the treatment of moderate-to-severe acne vulgaris; and FMX114, a combination of tofacitinib, whi...
More about VYNE
Track This Portfolio

Track Banque Cantonale Vaudoise Portfolio

Follow Banque Cantonale Vaudoise and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Banque Cantonale Vaudoise, based on Form 13F filings with the SEC.

News

Stay updated on Banque Cantonale Vaudoise with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email